Top Markets
#1 Islamic Coin Islamic Coin +152.50%
#2 Bitway Bitway +42.48%
#3 Starpower Starpower +38.69%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +33.29%
#5 aelf aelf +28.49%
#6 Pons Pons +26.56%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.55%
#8 SkyAI SkyAI +19.30%
#9 Ocean Protocol Ocean Protocol +16.33%
#10 Bedrock Bedrock +15.75%
Coin of the day
Islamic Coin Islamic Coin
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Onco-Innovations Ltd. Onco-Innovations Ltd.

Onco-Innovations Ltd.

ONCO
Rang in Aktien #29549
Onco-Innovations Ltd. is a Canadian biotechnology company primarily focused on... Onco-Innovations Ltd. is a Canadian biotechnology company primarily focused on pioneering cancer research and developing oncology treatments. A significant offering in their portfolio is ONC010, a product specifically designed for use in cancer therapies. This enterprise was founded on September 16, 2021, and conducts its operations from its headquarters located in Calgary, Canada.
Aktienkurs
$0.47705898
Zuletzt synchronisiert: 2026-07-15
Marktkapitalisierung
$20.69M
Veränderung (1 Tag)
3.17%
Veränderung (1 Jahr)
-65.19%
Land
CA
Handel Onco-Innovations Ltd. (ONCO)

Kategorie

Healthcare
Dividendenrendite-Verlauf für Onco-Innovations Ltd. (ONCO)
Dividendenrendite (TTM) von Onco-Innovations Ltd. (Aktienkürzel: ONCO) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Onco-Innovations Ltd. (ONCO) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR